Breaking News

Aterian Investment Partners to Recapitalize CPL

Will work alongside CPL’s stakeholders on the company’s next stage of growth.

Author Image

By: Charlie Sternberg

Associate Editor

An affiliate of Aterian Investment Partners, a private investment firm, has agreed to recapitalize Contract Pharmaceuticals Limited Canada (CPL), a North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.   CPL, based in Mississauga, Ontario, Canada, boasts longstanding relationships with 15 of the top 20 global pharmaceutical companies. The company supports its customers through its FDA and Health Canada-registered facilities...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters